Mehrdad Ghashghaeinia

6PUBLICATIONS
4CO-AUTHORS
Forensic epidemiologyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2021
Human erythrocytes, nuclear factor kappaB (NFκB) and hydrogen sulfide (H2S) - from non-genomic to genomic research.

Mehrdad Ghashghaeinia, Ulrich Mrowietz

|Dec 11, 2020
Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication.

Mehrdad Ghashghaeinia, Peter Dreischer, Thomas Wieder

|Nov 17, 2020
Association between nuclear factor of kappa B (NFκB) deficiency and induction of eryptosis in mouse erythrocytes.

Mehrdad Ghashghaeinia, Ulrich Mrowietz, Peter Dreischer

|Jul 09, 2020
The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis.

Mehrdad Ghashghaeinia, Pavla Koralkova, Daniela Giustarini

|Jun 04, 2019
Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes.

Mehrdad Ghashghaeinia, Martin Köberle, Ulrich Mrowietz

Pageof 1